CHF5993 pMDI 100/6/12.5 µg HFA-152a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF5993 pMDI 100/6/12.5 µg HFA-152a, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma [Phase 2]